CC
ALBO

Chicago Capital’s Albireo Pharma Inc ALBO Stock Holding History

Chicago Capital’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,362,484
Closed -$29.4M – 237
2022
Q4 		$29.4M Buy
1,362,484
+242,710
+22% +$5.13M 1.63% 27
2022
Q3 		$21.7M Sell
1,119,774
-231,460
-17% -$4.79M 1.25% 34
2022
Q2 		$26.8M Buy
1,351,234
+339,490
+34% +$8.96M 1.48% 30
2022
Q1 		$30.2M Buy
1,011,744
+162,505
+19% +$4.76M 1.3% 36
2021
Q4 		$19.8M Buy
849,239
+29,501
+4% +$784K 0.74% 44
2021
Q3 		$25.6M Buy
819,738
+122,502
+18% +$3.79M 0.97% 38
2021
Q2 		$24.5M Buy
697,236
+10,898
+2% +$354K 0.96% 40
2021
Q1 		$24.2M Buy
686,338
+68,075
+11% +$2.51M 1.02% 40
2020
Q4 		$23.2M Buy
618,263
+107,820
+21% +$3.92M 1.04% 40
2020
Q3 		$17M Buy
510,443
+8,231
+2% +$240K 0.88% 39
2020
Q2 		$13.3M Buy
502,212
+9,334
+2% +$220K 0.77% 40
2020
Q1 		$8.07M Buy
492,878
+317,589
+181% +$6.98M 0.65% 45
2019
Q4 		$4.46M Sell
175,289
-47,260
-21% -$945K 0.27% 59
2019
Q3 		$4.45M Buy
222,549
+20,308
+10% +$526K 0.3% 58
2019
Q2 		$6.52M Buy
202,241
+12,833
+7% +$429K 0.42% 58
2019
Q1 		$6.1M Buy
189,408
+8,497
+5% +$229K 0.41% 57
2018
Q4 		$4.44M Buy
180,911
+20,663
+13% +$546K 0.36% 56
2018
Q3 		$5.28M Buy
160,248
+25,500
+19% +$834K 0.37% 52
2018
Q2 		$4.78M Buy
134,748
+43,917
+48% +$1.42M 0.39% 54
2018
Q1 		$2.96M Buy
+90,831
New +$3.06M 0.39% 52

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Chicago Capital's ALBO Position: Q1 2023 in Review

Chicago Capital sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,362,484 shares — an estimated $29.4M sold.

Chicago Capital first reported a position in ALBO in Q1 2018 and held it in 20 quarters. The position peaked at $30.2M in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Chicago Capital reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Chicago Capital sold 1,362,484 Albireo Pharma Inc shares in Q1 2023, an estimated $29.4M.
  • Chicago Capital first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 20 quarters.
  • Chicago Capital's Albireo Pharma Inc position peaked at $30.2M in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Chicago Capital's 13F filing for Q1 2023, filed 18 Apr 2023.